nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR2A—arteriole—atherosclerosis	0.0334	0.171	CbGeAlD
Amisulpride—HTR7—vein—atherosclerosis	0.0319	0.163	CbGeAlD
Amisulpride—HTR2A—vein—atherosclerosis	0.0199	0.102	CbGeAlD
Amisulpride—Pregnancy—Lovastatin—atherosclerosis	0.014	0.0283	CcSEcCtD
Amisulpride—HTR2A—hindlimb—atherosclerosis	0.0132	0.0677	CbGeAlD
Amisulpride—Pregnancy—Simvastatin—atherosclerosis	0.0131	0.0265	CcSEcCtD
Amisulpride—HTR7—artery—atherosclerosis	0.013	0.0665	CbGeAlD
Amisulpride—HTR2A—appendage—atherosclerosis	0.0113	0.0581	CbGeAlD
Amisulpride—HTR7—endothelium—atherosclerosis	0.011	0.0562	CbGeAlD
Amisulpride—Hypokinesia—Niacin—atherosclerosis	0.0101	0.0204	CcSEcCtD
Amisulpride—HTR7—blood vessel—atherosclerosis	0.0101	0.0518	CbGeAlD
Amisulpride—Endocrine disorder—Simvastatin—atherosclerosis	0.00899	0.0181	CcSEcCtD
Amisulpride—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00841	0.017	CcSEcCtD
Amisulpride—HTR2A—artery—atherosclerosis	0.00811	0.0415	CbGeAlD
Amisulpride—Breast pain—Niacin—atherosclerosis	0.00784	0.0158	CcSEcCtD
Amisulpride—Gynaecomastia—Lovastatin—atherosclerosis	0.00713	0.0144	CcSEcCtD
Amisulpride—HTR2A—endothelium—atherosclerosis	0.00685	0.035	CbGeAlD
Amisulpride—Vaginal inflammation—Niacin—atherosclerosis	0.00684	0.0138	CcSEcCtD
Amisulpride—Gynaecomastia—Simvastatin—atherosclerosis	0.00667	0.0135	CcSEcCtD
Amisulpride—Vaginal infection—Niacin—atherosclerosis	0.00646	0.013	CcSEcCtD
Amisulpride—HTR2A—blood vessel—atherosclerosis	0.00631	0.0323	CbGeAlD
Amisulpride—Gynaecomastia—Pravastatin—atherosclerosis	0.00603	0.0122	CcSEcCtD
Amisulpride—HTR2B—cardiovascular system—atherosclerosis	0.00528	0.027	CbGeAlD
Amisulpride—Depression—Rosuvastatin—atherosclerosis	0.00524	0.0106	CcSEcCtD
Amisulpride—HTR7—connective tissue—atherosclerosis	0.00519	0.0266	CbGeAlD
Amisulpride—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00516	0.0104	CcSEcCtD
Amisulpride—HTR2B—adipose tissue—atherosclerosis	0.00465	0.0238	CbGeAlD
Amisulpride—Erectile dysfunction—Lovastatin—atherosclerosis	0.0046	0.00929	CcSEcCtD
Amisulpride—Orthostatic hypotension—Niacin—atherosclerosis	0.00454	0.00915	CcSEcCtD
Amisulpride—HTR7—cardiovascular system—atherosclerosis	0.00452	0.0231	CbGeAlD
Amisulpride—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00452	0.00911	CcSEcCtD
Amisulpride—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00437	0.00881	CcSEcCtD
Amisulpride—Erectile dysfunction—Simvastatin—atherosclerosis	0.00431	0.00869	CcSEcCtD
Amisulpride—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00429	0.00864	CcSEcCtD
Amisulpride—Depression—Simvastatin—atherosclerosis	0.00416	0.00839	CcSEcCtD
Amisulpride—Mental disorder—Rosuvastatin—atherosclerosis	0.00414	0.00834	CcSEcCtD
Amisulpride—Sweating increased—Pravastatin—atherosclerosis	0.00412	0.00831	CcSEcCtD
Amisulpride—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00409	0.00824	CcSEcCtD
Amisulpride—Erectile dysfunction—Niacin—atherosclerosis	0.00395	0.00798	CcSEcCtD
Amisulpride—Erectile dysfunction—Pravastatin—atherosclerosis	0.00389	0.00785	CcSEcCtD
Amisulpride—Weight increased—Pravastatin—atherosclerosis	0.00385	0.00776	CcSEcCtD
Amisulpride—Weight decreased—Pravastatin—atherosclerosis	0.00382	0.00772	CcSEcCtD
Amisulpride—Depression—Pravastatin—atherosclerosis	0.00376	0.00758	CcSEcCtD
Amisulpride—Angioedema—Rosuvastatin—atherosclerosis	0.00376	0.00758	CcSEcCtD
Amisulpride—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00369	0.00745	CcSEcCtD
Amisulpride—Angiopathy—Ezetimibe—atherosclerosis	0.00356	0.00718	CcSEcCtD
Amisulpride—Immune system disorder—Ezetimibe—atherosclerosis	0.00355	0.00715	CcSEcCtD
Amisulpride—Mental disorder—Ezetimibe—atherosclerosis	0.00344	0.00694	CcSEcCtD
Amisulpride—Malnutrition—Ezetimibe—atherosclerosis	0.00342	0.00689	CcSEcCtD
Amisulpride—Muscle spasms—Lovastatin—atherosclerosis	0.00335	0.00676	CcSEcCtD
Amisulpride—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00329	0.00664	CcSEcCtD
Amisulpride—Muscle spasms—Ezetimibe—atherosclerosis	0.00328	0.00663	CcSEcCtD
Amisulpride—Mental disorder—Simvastatin—atherosclerosis	0.00328	0.00661	CcSEcCtD
Amisulpride—Tremor—Lovastatin—atherosclerosis	0.00326	0.00658	CcSEcCtD
Amisulpride—HTR2A—connective tissue—atherosclerosis	0.00324	0.0166	CbGeAlD
Amisulpride—Angioedema—Lovastatin—atherosclerosis	0.00318	0.00642	CcSEcCtD
Amisulpride—Cardiac disorder—Pravastatin—atherosclerosis	0.00314	0.00633	CcSEcCtD
Amisulpride—Muscle spasms—Simvastatin—atherosclerosis	0.00313	0.00632	CcSEcCtD
Amisulpride—Angioedema—Ezetimibe—atherosclerosis	0.00312	0.0063	CcSEcCtD
Amisulpride—Angiopathy—Niacin—atherosclerosis	0.00312	0.00629	CcSEcCtD
Amisulpride—Leukopenia—Lovastatin—atherosclerosis	0.00312	0.00629	CcSEcCtD
Amisulpride—Tremor—Simvastatin—atherosclerosis	0.00305	0.00616	CcSEcCtD
Amisulpride—Insomnia—Rosuvastatin—atherosclerosis	0.00303	0.00612	CcSEcCtD
Amisulpride—Malnutrition—Niacin—atherosclerosis	0.00299	0.00603	CcSEcCtD
Amisulpride—Angioedema—Simvastatin—atherosclerosis	0.00298	0.00601	CcSEcCtD
Amisulpride—Anxiety—Lovastatin—atherosclerosis	0.00296	0.00596	CcSEcCtD
Amisulpride—Dyspepsia—Rosuvastatin—atherosclerosis	0.00295	0.00596	CcSEcCtD
Amisulpride—Hypertension—Ezetimibe—atherosclerosis	0.00295	0.00595	CcSEcCtD
Amisulpride—Tension—Niacin—atherosclerosis	0.00294	0.00592	CcSEcCtD
Amisulpride—Leukopenia—Simvastatin—atherosclerosis	0.00292	0.00588	CcSEcCtD
Amisulpride—Nervousness—Niacin—atherosclerosis	0.00291	0.00586	CcSEcCtD
Amisulpride—Dry mouth—Lovastatin—atherosclerosis	0.0029	0.00585	CcSEcCtD
Amisulpride—Tension—Pravastatin—atherosclerosis	0.00289	0.00583	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00289	0.00583	CcSEcCtD
Amisulpride—Muscle spasms—Niacin—atherosclerosis	0.00288	0.0058	CcSEcCtD
Amisulpride—Constipation—Rosuvastatin—atherosclerosis	0.00287	0.00579	CcSEcCtD
Amisulpride—Nervousness—Pravastatin—atherosclerosis	0.00286	0.00577	CcSEcCtD
Amisulpride—Dry mouth—Ezetimibe—atherosclerosis	0.00284	0.00574	CcSEcCtD
Amisulpride—Muscle spasms—Pravastatin—atherosclerosis	0.00283	0.00571	CcSEcCtD
Amisulpride—HTR2A—cardiovascular system—atherosclerosis	0.00282	0.0144	CbGeAlD
Amisulpride—HTR7—liver—atherosclerosis	0.00279	0.0143	CbGeAlD
Amisulpride—Anxiety—Simvastatin—atherosclerosis	0.00276	0.00558	CcSEcCtD
Amisulpride—Tremor—Pravastatin—atherosclerosis	0.00276	0.00557	CcSEcCtD
Amisulpride—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00274	0.00553	CcSEcCtD
Amisulpride—Nervous system disorder—Ezetimibe—atherosclerosis	0.00273	0.00552	CcSEcCtD
Amisulpride—Angioedema—Niacin—atherosclerosis	0.00273	0.00551	CcSEcCtD
Amisulpride—Skin disorder—Ezetimibe—atherosclerosis	0.00271	0.00546	CcSEcCtD
Amisulpride—Angioedema—Pravastatin—atherosclerosis	0.00269	0.00543	CcSEcCtD
Amisulpride—Leukopenia—Niacin—atherosclerosis	0.00268	0.0054	CcSEcCtD
Amisulpride—Urticaria—Rosuvastatin—atherosclerosis	0.00266	0.00538	CcSEcCtD
Amisulpride—Abdominal pain—Rosuvastatin—atherosclerosis	0.00265	0.00535	CcSEcCtD
Amisulpride—Leukopenia—Pravastatin—atherosclerosis	0.00264	0.00532	CcSEcCtD
Amisulpride—Insomnia—Lovastatin—atherosclerosis	0.00257	0.00519	CcSEcCtD
Amisulpride—Hypertension—Pravastatin—atherosclerosis	0.00254	0.00513	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00253	0.0051	CcSEcCtD
Amisulpride—Insomnia—Ezetimibe—atherosclerosis	0.00252	0.00509	CcSEcCtD
Amisulpride—Dyspepsia—Lovastatin—atherosclerosis	0.0025	0.00505	CcSEcCtD
Amisulpride—Anxiety—Pravastatin—atherosclerosis	0.0025	0.00504	CcSEcCtD
Amisulpride—Dry mouth—Niacin—atherosclerosis	0.00249	0.00502	CcSEcCtD
Amisulpride—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00247	0.00499	CcSEcCtD
Amisulpride—Dyspepsia—Ezetimibe—atherosclerosis	0.00245	0.00495	CcSEcCtD
Amisulpride—Fatigue—Lovastatin—atherosclerosis	0.00245	0.00494	CcSEcCtD
Amisulpride—Constipation—Lovastatin—atherosclerosis	0.00243	0.0049	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00241	0.00486	CcSEcCtD
Amisulpride—Asthenia—Rosuvastatin—atherosclerosis	0.00241	0.00486	CcSEcCtD
Amisulpride—Insomnia—Simvastatin—atherosclerosis	0.00241	0.00485	CcSEcCtD
Amisulpride—Fatigue—Ezetimibe—atherosclerosis	0.0024	0.00485	CcSEcCtD
Amisulpride—Constipation—Ezetimibe—atherosclerosis	0.00238	0.00481	CcSEcCtD
Amisulpride—Pruritus—Rosuvastatin—atherosclerosis	0.00237	0.00479	CcSEcCtD
Amisulpride—Skin disorder—Niacin—atherosclerosis	0.00237	0.00478	CcSEcCtD
Amisulpride—Hyperhidrosis—Niacin—atherosclerosis	0.00236	0.00476	CcSEcCtD
Amisulpride—Dyspepsia—Simvastatin—atherosclerosis	0.00234	0.00472	CcSEcCtD
Amisulpride—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00232	0.00469	CcSEcCtD
Amisulpride—Hyperhidrosis—Pravastatin—atherosclerosis	0.00232	0.00469	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.0023	0.00463	CcSEcCtD
Amisulpride—Diarrhoea—Rosuvastatin—atherosclerosis	0.0023	0.00463	CcSEcCtD
Amisulpride—Fatigue—Simvastatin—atherosclerosis	0.00229	0.00462	CcSEcCtD
Amisulpride—Hypotension—Niacin—atherosclerosis	0.00228	0.0046	CcSEcCtD
Amisulpride—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00228	0.0046	CcSEcCtD
Amisulpride—Constipation—Simvastatin—atherosclerosis	0.00227	0.00459	CcSEcCtD
Amisulpride—Urticaria—Lovastatin—atherosclerosis	0.00226	0.00456	CcSEcCtD
Amisulpride—Abdominal pain—Lovastatin—atherosclerosis	0.00225	0.00453	CcSEcCtD
Amisulpride—Dizziness—Rosuvastatin—atherosclerosis	0.00222	0.00447	CcSEcCtD
Amisulpride—Urticaria—Ezetimibe—atherosclerosis	0.00222	0.00447	CcSEcCtD
Amisulpride—Insomnia—Niacin—atherosclerosis	0.00221	0.00445	CcSEcCtD
Amisulpride—Abdominal pain—Ezetimibe—atherosclerosis	0.0022	0.00445	CcSEcCtD
Amisulpride—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00217	0.00439	CcSEcCtD
Amisulpride—Insomnia—Pravastatin—atherosclerosis	0.00217	0.00439	CcSEcCtD
Amisulpride—Somnolence—Niacin—atherosclerosis	0.00217	0.00438	CcSEcCtD
Amisulpride—Dyspepsia—Niacin—atherosclerosis	0.00215	0.00434	CcSEcCtD
Amisulpride—Dyspepsia—Pravastatin—atherosclerosis	0.00212	0.00427	CcSEcCtD
Amisulpride—Urticaria—Simvastatin—atherosclerosis	0.00211	0.00426	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Niacin—atherosclerosis	0.00211	0.00425	CcSEcCtD
Amisulpride—Abdominal pain—Simvastatin—atherosclerosis	0.0021	0.00424	CcSEcCtD
Amisulpride—Headache—Rosuvastatin—atherosclerosis	0.0021	0.00424	CcSEcCtD
Amisulpride—Hypersensitivity—Lovastatin—atherosclerosis	0.00209	0.00423	CcSEcCtD
Amisulpride—Fatigue—Pravastatin—atherosclerosis	0.00207	0.00418	CcSEcCtD
Amisulpride—Constipation—Pravastatin—atherosclerosis	0.00206	0.00415	CcSEcCtD
Amisulpride—Hypersensitivity—Ezetimibe—atherosclerosis	0.00205	0.00414	CcSEcCtD
Amisulpride—Asthenia—Lovastatin—atherosclerosis	0.00204	0.00411	CcSEcCtD
Amisulpride—Pruritus—Lovastatin—atherosclerosis	0.00201	0.00406	CcSEcCtD
Amisulpride—Asthenia—Ezetimibe—atherosclerosis	0.002	0.00404	CcSEcCtD
Amisulpride—Gastrointestinal pain—Niacin—atherosclerosis	0.002	0.00403	CcSEcCtD
Amisulpride—Nausea—Rosuvastatin—atherosclerosis	0.00199	0.00402	CcSEcCtD
Amisulpride—Pruritus—Ezetimibe—atherosclerosis	0.00197	0.00398	CcSEcCtD
Amisulpride—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00197	0.00397	CcSEcCtD
Amisulpride—Hypersensitivity—Simvastatin—atherosclerosis	0.00196	0.00395	CcSEcCtD
Amisulpride—Diarrhoea—Lovastatin—atherosclerosis	0.00195	0.00392	CcSEcCtD
Amisulpride—Urticaria—Niacin—atherosclerosis	0.00194	0.00391	CcSEcCtD
Amisulpride—Abdominal pain—Niacin—atherosclerosis	0.00193	0.00389	CcSEcCtD
Amisulpride—Urticaria—Pravastatin—atherosclerosis	0.00191	0.00385	CcSEcCtD
Amisulpride—Asthenia—Simvastatin—atherosclerosis	0.00191	0.00385	CcSEcCtD
Amisulpride—Diarrhoea—Ezetimibe—atherosclerosis	0.00191	0.00385	CcSEcCtD
Amisulpride—Abdominal pain—Pravastatin—atherosclerosis	0.0019	0.00383	CcSEcCtD
Amisulpride—Pruritus—Simvastatin—atherosclerosis	0.00188	0.00379	CcSEcCtD
Amisulpride—Dizziness—Lovastatin—atherosclerosis	0.00188	0.00379	CcSEcCtD
Amisulpride—Dizziness—Ezetimibe—atherosclerosis	0.00184	0.00372	CcSEcCtD
Amisulpride—Diarrhoea—Simvastatin—atherosclerosis	0.00182	0.00367	CcSEcCtD
Amisulpride—Vomiting—Lovastatin—atherosclerosis	0.00181	0.00365	CcSEcCtD
Amisulpride—Hypersensitivity—Niacin—atherosclerosis	0.0018	0.00363	CcSEcCtD
Amisulpride—Headache—Lovastatin—atherosclerosis	0.00178	0.00359	CcSEcCtD
Amisulpride—Vomiting—Ezetimibe—atherosclerosis	0.00177	0.00358	CcSEcCtD
Amisulpride—Hypersensitivity—Pravastatin—atherosclerosis	0.00177	0.00357	CcSEcCtD
Amisulpride—Dizziness—Simvastatin—atherosclerosis	0.00176	0.00355	CcSEcCtD
Amisulpride—Asthenia—Niacin—atherosclerosis	0.00175	0.00353	CcSEcCtD
Amisulpride—Headache—Ezetimibe—atherosclerosis	0.00175	0.00352	CcSEcCtD
Amisulpride—HTR2A—liver—atherosclerosis	0.00174	0.00892	CbGeAlD
Amisulpride—Pruritus—Niacin—atherosclerosis	0.00173	0.00348	CcSEcCtD
Amisulpride—Asthenia—Pravastatin—atherosclerosis	0.00172	0.00348	CcSEcCtD
Amisulpride—Pruritus—Pravastatin—atherosclerosis	0.0017	0.00343	CcSEcCtD
Amisulpride—Vomiting—Simvastatin—atherosclerosis	0.00169	0.00341	CcSEcCtD
Amisulpride—Nausea—Lovastatin—atherosclerosis	0.00169	0.00341	CcSEcCtD
Amisulpride—Diarrhoea—Niacin—atherosclerosis	0.00167	0.00337	CcSEcCtD
Amisulpride—Headache—Simvastatin—atherosclerosis	0.00167	0.00336	CcSEcCtD
Amisulpride—Nausea—Ezetimibe—atherosclerosis	0.00166	0.00334	CcSEcCtD
Amisulpride—Diarrhoea—Pravastatin—atherosclerosis	0.00164	0.00332	CcSEcCtD
Amisulpride—Dizziness—Niacin—atherosclerosis	0.00161	0.00326	CcSEcCtD
Amisulpride—Dizziness—Pravastatin—atherosclerosis	0.00159	0.00321	CcSEcCtD
Amisulpride—Nausea—Simvastatin—atherosclerosis	0.00158	0.00319	CcSEcCtD
Amisulpride—Vomiting—Niacin—atherosclerosis	0.00155	0.00313	CcSEcCtD
Amisulpride—Headache—Niacin—atherosclerosis	0.00153	0.00309	CcSEcCtD
Amisulpride—Vomiting—Pravastatin—atherosclerosis	0.00153	0.00308	CcSEcCtD
Amisulpride—Headache—Pravastatin—atherosclerosis	0.00151	0.00304	CcSEcCtD
Amisulpride—Nausea—Niacin—atherosclerosis	0.00145	0.00293	CcSEcCtD
Amisulpride—Nausea—Pravastatin—atherosclerosis	0.00143	0.00288	CcSEcCtD
Amisulpride—HTR7—Signaling Pathways—SOCS3—atherosclerosis	0.000104	0.000336	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KNG1—atherosclerosis	0.000103	0.000335	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—EDN1—atherosclerosis	0.000103	0.000335	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AGTR1—atherosclerosis	0.000103	0.000333	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL5—atherosclerosis	0.000103	0.000332	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CCL2—atherosclerosis	0.000101	0.000327	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CG—atherosclerosis	0.000101	0.000326	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP3—atherosclerosis	0.0001	0.000325	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PLG—atherosclerosis	0.0001	0.000325	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IGF2—atherosclerosis	9.99e-05	0.000323	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PRKCG—atherosclerosis	9.92e-05	0.000321	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VWF—atherosclerosis	9.87e-05	0.00032	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOC3—atherosclerosis	9.81e-05	0.000318	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PRKCG—atherosclerosis	9.76e-05	0.000316	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LDLR—atherosclerosis	9.75e-05	0.000316	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VWF—atherosclerosis	9.71e-05	0.000314	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—APOB—atherosclerosis	9.7e-05	0.000314	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOC3—atherosclerosis	9.65e-05	0.000313	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KNG1—atherosclerosis	9.63e-05	0.000312	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CXCL8—atherosclerosis	9.61e-05	0.000311	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AGT—atherosclerosis	9.61e-05	0.000311	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LDLR—atherosclerosis	9.59e-05	0.000311	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AGTR1—atherosclerosis	9.57e-05	0.00031	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EDN1—atherosclerosis	9.54e-05	0.000309	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL3—atherosclerosis	9.52e-05	0.000308	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SOCS3—atherosclerosis	9.49e-05	0.000307	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL5—atherosclerosis	9.47e-05	0.000307	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AGT—atherosclerosis	9.45e-05	0.000306	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCL2—atherosclerosis	9.39e-05	0.000304	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL3—atherosclerosis	9.37e-05	0.000303	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PLG—atherosclerosis	9.33e-05	0.000302	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—LPL—atherosclerosis	9.26e-05	0.0003	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP3—atherosclerosis	9.17e-05	0.000297	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IGF2—atherosclerosis	9.13e-05	0.000295	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NCF1—atherosclerosis	9.12e-05	0.000295	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PRKCG—atherosclerosis	9e-05	0.000291	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NCF1—atherosclerosis	8.97e-05	0.000291	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—F2—atherosclerosis	8.88e-05	0.000287	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOB—atherosclerosis	8.86e-05	0.000287	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SOCS3—atherosclerosis	8.83e-05	0.000286	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CXCL8—atherosclerosis	8.79e-05	0.000284	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SPP1—atherosclerosis	8.77e-05	0.000284	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—F2—atherosclerosis	8.73e-05	0.000283	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CXCL8—atherosclerosis	8.73e-05	0.000283	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AGT—atherosclerosis	8.72e-05	0.000282	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EDN1—atherosclerosis	8.72e-05	0.000282	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL5—atherosclerosis	8.65e-05	0.00028	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EDNRA—atherosclerosis	8.61e-05	0.000279	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCR2—atherosclerosis	8.61e-05	0.000279	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AGT—atherosclerosis	8.58e-05	0.000278	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CYBA—atherosclerosis	8.58e-05	0.000278	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP3—atherosclerosis	8.53e-05	0.000276	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CG—atherosclerosis	8.5e-05	0.000275	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF2—atherosclerosis	8.49e-05	0.000275	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCR2—atherosclerosis	8.48e-05	0.000274	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EDNRA—atherosclerosis	8.48e-05	0.000274	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—LPL—atherosclerosis	8.46e-05	0.000274	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CYBA—atherosclerosis	8.44e-05	0.000273	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GHRL—atherosclerosis	8.39e-05	0.000272	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PARP1—atherosclerosis	8.39e-05	0.000272	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PLAT—atherosclerosis	8.39e-05	0.000272	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CG—atherosclerosis	8.36e-05	0.000271	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GHRL—atherosclerosis	8.26e-05	0.000267	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PLAT—atherosclerosis	8.26e-05	0.000267	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PARP1—atherosclerosis	8.26e-05	0.000267	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOB—atherosclerosis	8.25e-05	0.000267	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PRKCG—atherosclerosis	8.23e-05	0.000266	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CXCL8—atherosclerosis	8.17e-05	0.000265	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PDGFB—atherosclerosis	8.11e-05	0.000263	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EDN1—atherosclerosis	8.11e-05	0.000263	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—F2—atherosclerosis	8.06e-05	0.000261	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL5—atherosclerosis	8.05e-05	0.000261	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SPP1—atherosclerosis	8.01e-05	0.000259	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CXCL8—atherosclerosis	7.98e-05	0.000258	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—F2—atherosclerosis	7.93e-05	0.000257	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AGT—atherosclerosis	7.92e-05	0.000256	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—LPL—atherosclerosis	7.87e-05	0.000255	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—LEP—atherosclerosis	7.76e-05	0.000251	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—APOE—atherosclerosis	7.76e-05	0.000251	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CG—atherosclerosis	7.71e-05	0.00025	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CAV1—atherosclerosis	7.69e-05	0.000249	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—APOA1—atherosclerosis	7.67e-05	0.000248	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PRKCG—atherosclerosis	7.65e-05	0.000248	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CG—atherosclerosis	7.59e-05	0.000246	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SPP1—atherosclerosis	7.46e-05	0.000241	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CXCL8—atherosclerosis	7.42e-05	0.00024	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PDGFB—atherosclerosis	7.41e-05	0.00024	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ESR1—atherosclerosis	7.41e-05	0.00024	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KNG1—atherosclerosis	7.37e-05	0.000239	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AGTR1—atherosclerosis	7.32e-05	0.000237	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—F2—atherosclerosis	7.32e-05	0.000237	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KNG1—atherosclerosis	7.25e-05	0.000235	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AGT—atherosclerosis	7.24e-05	0.000234	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGTR1—atherosclerosis	7.21e-05	0.000233	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL2—atherosclerosis	7.18e-05	0.000233	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PLG—atherosclerosis	7.14e-05	0.000231	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—LEP—atherosclerosis	7.09e-05	0.00023	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOE—atherosclerosis	7.09e-05	0.00023	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL2—atherosclerosis	7.07e-05	0.000229	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CAV1—atherosclerosis	7.03e-05	0.000227	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PLG—atherosclerosis	7.02e-05	0.000227	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOA1—atherosclerosis	7.01e-05	0.000227	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CG—atherosclerosis	7e-05	0.000227	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PDGFB—atherosclerosis	6.9e-05	0.000223	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ESR1—atherosclerosis	6.77e-05	0.000219	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SOCS3—atherosclerosis	6.76e-05	0.000219	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AGT—atherosclerosis	6.74e-05	0.000218	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—MAPK3—atherosclerosis	6.71e-05	0.000217	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—F2—atherosclerosis	6.69e-05	0.000217	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SOCS3—atherosclerosis	6.65e-05	0.000215	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—INS—atherosclerosis	6.63e-05	0.000215	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—LEP—atherosclerosis	6.6e-05	0.000214	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOE—atherosclerosis	6.6e-05	0.000214	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CAV1—atherosclerosis	6.54e-05	0.000212	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP3—atherosclerosis	6.53e-05	0.000211	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOA1—atherosclerosis	6.52e-05	0.000211	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL2—atherosclerosis	6.52e-05	0.000211	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF2—atherosclerosis	6.5e-05	0.00021	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP3—atherosclerosis	6.42e-05	0.000208	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IGF1—atherosclerosis	6.41e-05	0.000208	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CG—atherosclerosis	6.4e-05	0.000207	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF2—atherosclerosis	6.39e-05	0.000207	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOB—atherosclerosis	6.31e-05	0.000204	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ESR1—atherosclerosis	6.3e-05	0.000204	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCL8—atherosclerosis	6.26e-05	0.000203	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—F2—atherosclerosis	6.22e-05	0.000201	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EDN1—atherosclerosis	6.21e-05	0.000201	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOB—atherosclerosis	6.21e-05	0.000201	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL5—atherosclerosis	6.16e-05	0.000199	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCL8—atherosclerosis	6.16e-05	0.000199	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—MAPK3—atherosclerosis	6.13e-05	0.000198	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EDN1—atherosclerosis	6.11e-05	0.000198	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SERPINE1—atherosclerosis	6.09e-05	0.000197	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL5—atherosclerosis	6.06e-05	0.000196	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—INS—atherosclerosis	6.06e-05	0.000196	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LPL—atherosclerosis	6.02e-05	0.000195	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL2—atherosclerosis	5.96e-05	0.000193	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CG—atherosclerosis	5.96e-05	0.000193	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LPL—atherosclerosis	5.93e-05	0.000192	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IGF1—atherosclerosis	5.86e-05	0.00019	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PRKCG—atherosclerosis	5.86e-05	0.00019	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NOS3—atherosclerosis	5.81e-05	0.000188	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PRKCG—atherosclerosis	5.76e-05	0.000187	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SPP1—atherosclerosis	5.71e-05	0.000185	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—MAPK3—atherosclerosis	5.7e-05	0.000185	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	5.68e-05	0.000184	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—INS—atherosclerosis	5.64e-05	0.000183	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SPP1—atherosclerosis	5.61e-05	0.000182	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCL8—atherosclerosis	5.59e-05	0.000181	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SERPINE1—atherosclerosis	5.57e-05	0.00018	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL2—atherosclerosis	5.55e-05	0.00018	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF1—atherosclerosis	5.45e-05	0.000177	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NOS3—atherosclerosis	5.31e-05	0.000172	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PDGFB—atherosclerosis	5.28e-05	0.000171	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	5.19e-05	0.000168	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SERPINE1—atherosclerosis	5.18e-05	0.000168	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCL8—atherosclerosis	5.16e-05	0.000167	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AGT—atherosclerosis	5.15e-05	0.000167	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGT—atherosclerosis	5.07e-05	0.000164	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOE—atherosclerosis	5.05e-05	0.000163	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LEP—atherosclerosis	5.05e-05	0.000163	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CAV1—atherosclerosis	5e-05	0.000162	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOA1—atherosclerosis	4.99e-05	0.000162	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—atherosclerosis	4.98e-05	0.000161	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOE—atherosclerosis	4.97e-05	0.000161	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LEP—atherosclerosis	4.97e-05	0.000161	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NOS3—atherosclerosis	4.94e-05	0.00016	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CAV1—atherosclerosis	4.92e-05	0.000159	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOA1—atherosclerosis	4.91e-05	0.000159	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—atherosclerosis	4.9e-05	0.000159	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ESR1—atherosclerosis	4.82e-05	0.000156	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—F2—atherosclerosis	4.76e-05	0.000154	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ESR1—atherosclerosis	4.74e-05	0.000154	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCL8—atherosclerosis	4.71e-05	0.000153	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—F2—atherosclerosis	4.69e-05	0.000152	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—atherosclerosis	4.66e-05	0.000151	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NFKB1—atherosclerosis	4.62e-05	0.000149	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	4.56e-05	0.000148	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—atherosclerosis	4.55e-05	0.000147	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAPK8—atherosclerosis	4.54e-05	0.000147	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—atherosclerosis	4.52e-05	0.000146	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	4.48e-05	0.000145	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—atherosclerosis	4.48e-05	0.000145	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL8—atherosclerosis	4.39e-05	0.000142	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	4.36e-05	0.000141	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—INS—atherosclerosis	4.31e-05	0.00014	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	4.29e-05	0.000139	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—atherosclerosis	4.26e-05	0.000138	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—INS—atherosclerosis	4.24e-05	0.000137	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL2—atherosclerosis	4.24e-05	0.000137	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—atherosclerosis	4.24e-05	0.000137	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NFKB1—atherosclerosis	4.22e-05	0.000137	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VEGFA—atherosclerosis	4.19e-05	0.000136	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL2—atherosclerosis	4.18e-05	0.000135	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF1—atherosclerosis	4.17e-05	0.000135	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—atherosclerosis	4.17e-05	0.000135	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—STAT3—atherosclerosis	4.15e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK8—atherosclerosis	4.15e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—atherosclerosis	4.13e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1—atherosclerosis	4.11e-05	0.000133	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—atherosclerosis	3.97e-05	0.000128	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAPK3—atherosclerosis	3.96e-05	0.000128	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	3.96e-05	0.000128	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NFKB1—atherosclerosis	3.92e-05	0.000127	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	3.9e-05	0.000126	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK8—atherosclerosis	3.86e-05	0.000125	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—atherosclerosis	3.85e-05	0.000125	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TGFB1—atherosclerosis	3.84e-05	0.000124	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VEGFA—atherosclerosis	3.83e-05	0.000124	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—STAT3—atherosclerosis	3.79e-05	0.000123	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOS3—atherosclerosis	3.78e-05	0.000122	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOS3—atherosclerosis	3.72e-05	0.000121	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK3—atherosclerosis	3.62e-05	0.000117	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VEGFA—atherosclerosis	3.56e-05	0.000115	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STAT3—atherosclerosis	3.53e-05	0.000114	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	3.51e-05	0.000114	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK3—atherosclerosis	3.37e-05	0.000109	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL8—atherosclerosis	3.36e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	3.3e-05	0.000107	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFB1—atherosclerosis	3.27e-05	0.000106	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	3.24e-05	0.000105	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—atherosclerosis	3.19e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	3.19e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—atherosclerosis	3.14e-05	0.000102	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—atherosclerosis	3.04e-05	9.83e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NFKB1—atherosclerosis	3e-05	9.72e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—atherosclerosis	2.99e-05	9.67e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	2.95e-05	9.57e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK8—atherosclerosis	2.95e-05	9.56e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—atherosclerosis	2.94e-05	9.53e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	2.9e-05	9.4e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—atherosclerosis	2.9e-05	9.38e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	2.9e-05	9.38e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VEGFA—atherosclerosis	2.73e-05	8.82e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STAT3—atherosclerosis	2.7e-05	8.74e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	2.68e-05	8.68e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—atherosclerosis	2.67e-05	8.65e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STAT3—atherosclerosis	2.66e-05	8.6e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—atherosclerosis	2.65e-05	8.57e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK3—atherosclerosis	2.58e-05	8.35e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	2.54e-05	8.21e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFB1—atherosclerosis	2.5e-05	8.1e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—atherosclerosis	2.46e-05	7.98e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	2.46e-05	7.97e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—atherosclerosis	2.44e-05	7.91e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—atherosclerosis	2.27e-05	7.36e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—atherosclerosis	1.89e-05	6.1e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—atherosclerosis	1.85e-05	6e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.74e-05	5.63e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.71e-05	5.54e-05	CbGpPWpGaD
